Calling ALL Type 1 Diabetes and LADA Patients – share this breakthrough with your family members

Calling ALL Type 1 Diabetes and LADA Patients – share this breakthrough with your family members

At the beginning of 2023, Dr. Graham, MD., Board Certified Endocrinologist & Diabetologist as well as Founder and Medical Director of Diabetes & Endocrine Treatment Specialists (DETS, for short) sent a letter to all patients in our clinic that have Type 1 Diabetes and LADA (Latent Autoimmune Diabetes in Adults).

The letter states that there is a REVOLUTIONARY FIRST and ONLY FDA-approved treatment prevent to DELAY the onset of Type 1 diabetes, called Tzield.

Dr. Graham goes on to say:

Family members of people with Type 1 diabetes and LADA are at a much higher risk for contracting diabetes themselves. So far, there has never been a way to medically prevent diabetes in our family. Many of our family members have had blood tests positive for Type 1 diabetes antibodies, which are the key indicators of the earliest stages of Type 1 diabetes, but there has never been a way to prevent or delay the eventual onset of diabetes for them. This all changed practically overnight. We can now do something to stop Type 1 diabetes in its tracks.

He then describes more about the medication called Tzield.

On November 17, 2022, the FDA approved Tzield, the first medication that will effectively prevent full-blown Type 1 diabetes in family members at high risk. Tzield can protect people with positive antibody testing and early signs of abnormal blood sugar from developing diabetes.

Tzield is an IV medication given once per day for just 14 days. Minor side effects have been reported but they can be monitored. No further treatments are needed afterward. This short course of treatment is sufficient to “reprogram” the immune system for several years so that it stops attacking the insulin-producing cells in the pancreas.

Of the participants in the clinical trials for Tzield 5 years after receiving the medication, only 43% developed diabetes vs. 72% who had been given the placebo, a remarkable 60% reduction in diabetes risk!

Who should be tested?

Dr. Graham and DETS feel strongly that Tzield is a game-changer and that all close relatives (8 years or older) of Type 1 and LADA people should be tested. Our clinic will even coordinate laboratory blood testing and you do not have to be an existing patient in our clinic. We will send orders to the preferred in-network laboratory where insurance should cover the tests. Then, Dr. Graham will review the results and let you know how to proceed further as warranted.

Click here to be taken to the Tzield information page.

To arrange for testing, family members should email DETS at or text DETS at 801-816-1010. When text-messaging us, specifically mention “Tzield” so we can get their message to the right team members.

Call Today For Your Appointment